Last reviewed · How we verify
Administration of METHOXYFLURANE
At a glance
| Generic name | Administration of METHOXYFLURANE |
|---|---|
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Use of the Methoxyflurane as Pain-killer in the Prehospital Management of Acute Myocardial Infarction (PHASE3)
- 3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion (PHASE4)
- METHOXYFLURANE or Virtual Reality Headset vs Standard Analgesic Management for the Reduction of Anterior Shoulder Dislocation (HYPNOLUX) (PHASE4)
- Study of the Use of Methoxyflurane vs Placebo in the Management of Pain in Oral and Dental Emergencies in Adults: METODO (METhoxyflurane in ODOntology) (PHASE3)
- Methoxyflurane Analgesia for Paediatric Injuries (PHASE3)
- Prehospital Analgesia in Adults Using Inhaled Methoxyflurane Study (PHASE4)
- A Comparison of Three Regimens of Acute Pain Management: Methoxyflurane; Intranasal Fentanyl; Intravenous Morphine (PHASE3)
- ANalgesic Efficacy and Safety of MOrphiNe Versus Methoxyflurane in Patients With Acute Myocardial Infarction (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: